Screener
Company's interest in settlement amount, percent
Arbutus Biopharma Corporation·Products & Services·1 segment
Breakdown
Segments
Revenue from collaborations and licensesView metric
| Segment | Q1 '26 |
|---|---|
| Revenue from collaborations and licenses | 20% |
| Total | 20% |